DOI: 10.12890/2024_004832

Esophageal damage following left atrial ablation in a patient on dabigatran: adding insult to injury

Authors

  • Sarah Jalloul Department of Gastroenterology, Faculty of Medicine, University of Balamand, El Koura, Lebanon
  • Chris Jreij Department of Internal Medicine, Faculty of Medicine, University of Balamand, El Koura, Lebanon
  • Karam Karam Department of Gastroenterology, Faculty of Medicine, University of Balamand, El Koura, Lebanon
  • Johny Salem Department of Internal Medicine, Faculty of Medicine, University of Balamand, El Koura, Lebanon
  • Louis Chaptini Department of Gastroenterology, Faculty of Medicine, University of Balamand, El Koura, Lebanon; Department of Medicine, Digestive Diseases, Yale School of Medicine, New Haven, USA

louis.chaptini@yale.edu

Keywords

Sloughing esophagitis, left atrial ablation, dabigatran-induced esophagitis

Abstract

Dabigatran, a commonly prescribed anticoagulant medication, has been associated with esophagitis, referred to as dabigatran-induced esophagitis (DIE). We report a case of DIE occurring in a patient following left atrial ablation for atrial fibrillation. This case emphasizes the importance of recognizing the possible combined detrimental effects of left atrial ablation and dabigatran on the esophageal mucosa and highlights the clinical and endoscopic characteristics associated with DIE.

View the entire article

Downloads

References

  1. Qumseya BJ, Kusumoto F, Wolfsen H. Esophageal injury following left atrial ablation. Gastroenterol Hepatol (NY) 2012;8:414-416.
  2. Lemola K, Sneider M, Desjardins B, Case I, Han J, Good E, et al. Computed tomographic analysis of the anatomy of the left atrium and the esophagus: implications for left atrial catheter ablation. Circulation 2004;110:3655-3660.
  3. Zhou Y, Dai Y, Lu L, Fu Z. Dabigatran-induced esophagitis: A case report. Medicine (Baltimore) 2020;99:e19890.
  4. Toya Y, Nakamura S, Tomita K, Matsuda N, Abe K, Abiko Y, et al. Dabigatran-induced esophagitis: The prevalence and endoscopic characteristics. J Gastroenterol Hepatol 2016;31:610-614.
  5. Shibagaki K, Taniguchi H, Goto D, Kobayashi K, Kinoshita Y. Dabigatran-induced asymptomatic esophageal mucosal injury. Gastrointest Endosc 2016;83:472- 474.
  6. Singh S, Savage L, Klein M, Thomas C. Severe necrotic oesophageal and gastric ulceration associated with dabigatran. BMJ Case Rep 2013;2013:bcr2013009139.
  7. Ito Y, Igawa M, Nogami A, K. Aonuma. Dabigatran-induced esophagitis after radiofrequency catheter ablation. Eur Heart J 2017;38:doi: 10.1093/eurheartj/ehx504.2875.

Published

2024-09-12

Issue

Vol. 11 No. 10 (2024)

Categories

How to Cite

1.
Jalloul S, Jreij C, Karam K, Salem J, Chaptini L. Esophageal damage following left atrial ablation in a patient on dabigatran: adding insult to injury. EJCRIM [Internet]. 2024 Sep. 12 [cited 2026 Nov. 3];11(10). Available from: https://ejcrim.com/index.php/ejcrim/article/view/4832

Most read articles by the same author(s)

1 2 3 > >>